Ozyılkan O - Search Results

1

Malignant pleural mesothelioma: a single-center experience in Turkey.

Sezer A, Sümbül AT, Abalı H, Mertsoylu H, Ozyılkan O. Sezer A, et al. Among authors: ozyilkan o. Med Sci Monit. 2014 May 20;20:825-32. doi: 10.12659/MSM.890020. Med Sci Monit. 2014. PMID: 24842043 Free PMC article.

2

Multiple myeloma with pleural involvement: a case report.

Ulubay G, Eyüboğlu FO, Simşek A, Ozyilkan O. Ulubay G, et al. Among authors: ozyilkan o. Am J Clin Oncol. 2005 Aug;28(4):429-30. doi: 10.1097/01.coc.0000144816.97535.31. Am J Clin Oncol. 2005. PMID: 16062090

3

Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.

Kose F, Abali H, Sezer A, Mertsoylu H, Disel U, Ozyilkan O. Kose F, et al. Among authors: ozyilkan o. Leuk Lymphoma. 2009 Feb;50(2):282-3. doi: 10.1080/10428190802603169. Leuk Lymphoma. 2009. PMID: 19197737 No abstract available.

4

Colon adenocarcinoma and solitary tibia metastasis: rare entity.

Kose F, Sakalli H, Sezer A, Mertsoylu H, Pourbagher A, Reyhan M, Ozyilkan O. Kose F, et al. Among authors: ozyilkan o. J Gastrointest Cancer. 2008;39(1-4):146-8. doi: 10.1007/s12029-009-9055-1. Epub 2009 Feb 25. J Gastrointest Cancer. 2008. PMID: 19241183

5

Primary renal lymphoma: report of four cases.

Kose F, Sakalli H, Mertsoylu H, Sezer A, Kocer E, Tokmak N, Kilinc F, Ozyilkan O. Kose F, et al. Among authors: ozyilkan o. Onkologie. 2009 Apr;32(4):200-2. doi: 10.1159/000203331. Epub 2009 Mar 13. Onkologie. 2009. PMID: 19372716

6

Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.

Disel U, Gürkut O, Abali H, Kaleağasi H, Mertsoylu H, Ozyilkan O, Saif MW. Disel U, et al. Among authors: ozyilkan o. Cutan Ocul Toxicol. 2010 Jun;29(2):140-2. doi: 10.3109/15569521003699585. Cutan Ocul Toxicol. 2010. PMID: 20298142

7

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Dişel U, Oztuzcu S, Beşen AA, Karadeniz C, Köse F, Sümbül AT, Sezer A, Nursal GN, Abalı H, Ozyılkan O. Dişel U, et al. Among authors: ozyilkan o. Lung Cancer. 2011 Jan;71(1):109-12. doi: 10.1016/j.lungcan.2010.09.011. Lung Cancer. 2011. PMID: 20970876

8

Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience.

Kose F, Oguzkurt L, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Mertsoylu H, Ozyilkan O. Kose F, et al. Among authors: ozyilkan o. Eur J Radiol. 2012 Aug;81(8):1724-7. doi: 10.1016/j.ejrad.2011.04.056. Epub 2011 May 18. Eur J Radiol. 2012. PMID: 21596502

9

Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience.

Kose F, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Altundag O, Ozyilkan O. Kose F, et al. Among authors: ozyilkan o. Asian Pac J Cancer Prev. 2011;12(5):1185-8. Asian Pac J Cancer Prev. 2011. PMID: 21875263 Free article.

10

Hypertension associated with angiogoenesis inhibitors: what do oncologists really do in daily routine? A small survey.

Dişel U, Abalı H, Sümbül AT, Ozyılkan O. Dişel U, et al. Among authors: ozyilkan o. J Clin Hypertens (Greenwich). 2011 Nov;13(11):863. doi: 10.1111/j.1751-7176.2011.00526.x. Epub 2011 Aug 24. J Clin Hypertens (Greenwich). 2011. PMID: 22051434 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters